0001415889-23-006023.txt : 20230404
0001415889-23-006023.hdr.sgml : 20230404
20230404163252
ACCESSION NUMBER: 0001415889-23-006023
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230331
FILED AS OF DATE: 20230404
DATE AS OF CHANGE: 20230404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kurzius Lawrence Erik
CENTRAL INDEX KEY: 0001352090
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38661
FILM NUMBER: 23798318
MAIL ADDRESS:
STREET 1: 18 LOVETON CIRCLE
CITY: SPARKS
STATE: MD
ZIP: 21152
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elanco Animal Health Inc
CENTRAL INDEX KEY: 0001739104
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 825497352
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
BUSINESS PHONE: 877-352-6261
MAIL ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
4
1
form4-04042023_080424.xml
X0407
4
2023-03-31
0001739104
Elanco Animal Health Inc
ELAN
0001352090
Kurzius Lawrence Erik
C/O ELANCO ANIMAL HEALTH INCORPORATED
2500 INNOVATION WAY
GREENFIELD
IN
46140
true
false
false
false
0
Deferred Stock Units
2023-03-31
4
A
0
2925.5319
9.40
A
Common Stock
2925.5319
18140.0999
D
Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.
The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.
The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $9.40 on March 31, 2023.
/s/ Catherine S. Powell, as Attorney-in-Fact for Lawrence Kurzius
2023-04-04